Management of von Willebrand's disease.
Logan
L J
LJ
Univ. of So. California School of Medicine, Department of Clinical Medicine, Pasadena 91105.
D005169:Factor VIII / Q000378:metabolism / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy; D006801:Humans; D007518:Isoantibodies / Q000096:biosynthesis; D012307:Risk Factors; D014842:von Willebrand Diseases / Q000150:complications / Q000628:therapy*; D014841:von Willebrand Factor / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use
D007518:Isoantibodies; D014841:von Willebrand Factor; D005169:Factor VIII